معرفی
Bernard Brais serves as Director of the Rare Neurological Diseases Group at the Montreal Neurological Institute-Hospital (The Neuro), which operates as a McGill University research and teaching institute and is part of the Neuroscience Mission of the McGill University Health Centre. His academic appointment at McGill University positions him within one of Canada's premier neuroscience research environments.
Dr. Brais completed his MDCM, neurology residency, and PhD at McGill University, establishing his deep institutional connections. He additionally possesses specialized training as a historian of neurosciences and genetics, which informs his comprehensive approach to neurological disorders.
His research program centers on the genetic basis of neurogenetic disorders with founder effects in Quebec populations, with particular emphasis on disorders exhibiting ataxic manifestations such as Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS). Since 2007, he has led a dedicated research team investigating ARSACS, building on his earlier work identifying causal genes for Oculopharyngeal muscular dystrophy (OPMD), Hereditary Sensory and Autonomic Neuropathy type II (HSANII), Limb Girdle Muscular Dystrophy with Quadriceps atrophy (LGMD2L), Pol III-related leukodystrophies, and ZAK congenital myopathy.
Analysis of Dr. Brais's publication record reveals a cohesive research trajectory spanning clinical studies of disease progression, molecular genetics investigations of causal mutations, and preclinical work with animal models. His work consistently focuses on rare neurological conditions with strong genetic components, particularly those showing founder effects in Quebec populations, with substantial contributions to understanding neuromuscular disorders, ataxias, leukodystrophies, and neuropathies.
As Director of the Rare Neurological Diseases research group, Dr. Brais oversees multiple research initiatives investigating various rare neurological conditions. His laboratory work integrates clinical research with basic science approaches, utilizing patient populations for clinical studies while employing cellular and animal models to elucidate disease mechanisms. His clinical work is associated with the Neuromuscular Programme at The Neuro, where he applies his research findings to patient care.
